SPL
Click for more information
9.20% 9.5¢ starpharma holdings limited

Ann: DEP docetaxel positive phase 1 results, phase 2 commences, page-103

  1. antibotter
    12,800 Posts.
    lightbulb Created with Sketch. 1392
    clock Created with Sketch.
    25/09/17
    14:24
    Post #: 27439584
    Well said Joohnno

    Just like to add so there is no confusion

    The combination therapy (DEP® docetaxel + Nintedanib) part of the trial will begin immediately and in parallel/ at same time as initiation of the monotherapy part of  DEP® docetaxel trial



    I would also like to suggest there was profit taking earlier on this morning which took share price lower

    Could break 1.25 today

    Here's hoping
    Last edited by antibotter: 25/09/17
    SPL Price at posting: $1.20 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢ 		Change
0.008(9.20%) 		Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.